torrent

PHARMA
2°4 August, 2025
The Dy. General Manager (Listing Dept.) The Manager — Listing Dept.,
BSE Limited, National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5" Floor,
1* Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai — 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,

Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations,
2015, this is to inform you that:

e The USFDA inspected our manufacturing facility at Vizag, Andhra Pradesh from
28-Jul-25 to 01-Aug-25
e The Inspection has been concluded with Zero observation.

Please take the information on your records.
Thanking you,
Yours Sincerely

For TORRENT PHARMACEUTICALS LIMITED
M TRIVEDI 2s

CHINTAN M. TRIVEDI

COMPANY SECRETARY

TORRENT PHARMACEUTICALS LIMITED
CIN: L24230GJ1972PLC002126
Reg.Office : Torrent House, Off Ashram Road, Anmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100,
www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com
